Yue Wei1, Ning Zhang1, Qi Jin1, Wenqi Pan1, Yucai Xie1, Kang Chen1, Tianyou Ling1, Changjian Lin1, Yangyang Bao1, Qingzhi Luo1, Chaofan Xing1, Liqun Wu2. 1. Department of Cardiology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin No. 2 Road, Shanghai, 201204, China. 2. Department of Cardiology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin No. 2 Road, Shanghai, 201204, China. wuliqun8907@163.com.
Abstract
BACKGROUND: Laser balloon (LB) and cryoballoon (CB) ablation are two balloon-based catheter ablation technologies used for atrial fibrillation (AF) ablation in recent years. However, the efficacy and the safety of LB ablation in comparison to CB ablation remained indeterminate. We sought to compare these two technologies by conducting meta-analysis of previous studies using both the CB and LB ablation systems for AF ablation. METHODS: We searched electronic scientific databases for studies of LB vs. CB ablation in AF patients. The procedural efficacy was assessed by the success of acute pulmonary vein isolation (PVI) and the 12-month recurrence of any atrial arrhythmia, and the safety was evaluated by the risk of procedure-related complications. RESULTS: A total of 595 participants (LB, n = 292 vs. CB, n = 303) from eight studies were included in this meta-analysis. Risk of acute PVI failure (risk ratio, RR 95% confidence interval [95% CI] = 2.55 [0.86-7.56], P = 0.09) and atrial arrhythmia recurrence in 12 months (RR [95% CI] = 0.91 [0.64-1.28], P = 0.59) were comparable between LB vs. CB ablation, and LB ablation tended to be more effective than CB ablation in paroxysmal AF patients (RR [95% CI] = 0.70 [0.47-1.03], P = 0.07). Risk of procedure-related complications was similar while LB ablation showed slightly higher risk without statistic significance (LB 13.9% vs. CB 9.3%, RR [95% CI] = 1.52 [0.88-2.64], P = 0.14). Compared with CB ablation, LB ablation led to longer procedure duration (weighted mean differences WMD [95% CI] =29.7 [15.8-43.7], P < 0.001) while similar fluoroscopy duration was observed between these two ablation devices (WMD [95% CI] = - 1.99[- 6.46-2.47], P = 0.38). CONCLUSIONS: LB ablation has a trend toward higher procedural efficacy compared with CB ablation in paroxysmal AF patients. However, longer procedure duration and a statistically non-significant trend of more procedure-related complications were also observed in patients ablated by LB. Further larger comparative randomized trials are warranted to disclose the impact of LB compared with CB for ablation of AF.
BACKGROUND: Laser balloon (LB) and cryoballoon (CB) ablation are two balloon-based catheter ablation technologies used for atrial fibrillation (AF) ablation in recent years. However, the efficacy and the safety of LB ablation in comparison to CB ablation remained indeterminate. We sought to compare these two technologies by conducting meta-analysis of previous studies using both the CB and LB ablation systems for AF ablation. METHODS: We searched electronic scientific databases for studies of LB vs. CB ablation in AFpatients. The procedural efficacy was assessed by the success of acute pulmonary vein isolation (PVI) and the 12-month recurrence of any atrial arrhythmia, and the safety was evaluated by the risk of procedure-related complications. RESULTS: A total of 595 participants (LB, n = 292 vs. CB, n = 303) from eight studies were included in this meta-analysis. Risk of acute PVI failure (risk ratio, RR 95% confidence interval [95% CI] = 2.55 [0.86-7.56], P = 0.09) and atrial arrhythmia recurrence in 12 months (RR [95% CI] = 0.91 [0.64-1.28], P = 0.59) were comparable between LB vs. CB ablation, and LB ablation tended to be more effective than CB ablation in paroxysmal AFpatients (RR [95% CI] = 0.70 [0.47-1.03], P = 0.07). Risk of procedure-related complications was similar while LB ablation showed slightly higher risk without statistic significance (LB 13.9% vs. CB 9.3%, RR [95% CI] = 1.52 [0.88-2.64], P = 0.14). Compared with CB ablation, LB ablation led to longer procedure duration (weighted mean differences WMD [95% CI] =29.7 [15.8-43.7], P < 0.001) while similar fluoroscopy duration was observed between these two ablation devices (WMD [95% CI] = - 1.99[- 6.46-2.47], P = 0.38). CONCLUSIONS:LB ablation has a trend toward higher procedural efficacy compared with CB ablation in paroxysmal AFpatients. However, longer procedure duration and a statistically non-significant trend of more procedure-related complications were also observed in patients ablated by LB. Further larger comparative randomized trials are warranted to disclose the impact of LB compared with CB for ablation of AF.
Authors: Srinivas R Dukkipati; Petr Neuzil; Josef Kautzner; Jan Petru; Dan Wichterle; Jan Skoda; Robert Cihak; Petr Peichl; Antonio Dello Russo; Gemma Pelargonio; Claudio Tondo; Andrea Natale; Vivek Y Reddy Journal: Heart Rhythm Date: 2012-01-28 Impact factor: 6.343
Authors: Boris Schmidt; Melanie Gunawardene; Detlef Krieg; Stefano Bordignon; Alexander Fürnkranz; Mehmet Kulikoglu; Wilfried Herrmann; K R Julian Chun Journal: J Cardiovasc Electrophysiol Date: 2013-04-18
Authors: Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin Journal: J Am Coll Cardiol Date: 2013-03-21 Impact factor: 24.094
Authors: Yasuo Okumura; Benhur D Henz; T Jared Bunch; Charles Dalegrave; Susan B Johnson; Douglas L Packer Journal: J Cardiovasc Electrophysiol Date: 2009-06-03
Authors: Thomas Neumann; Jürgen Vogt; Burghard Schumacher; Anja Dorszewski; Malte Kuniss; Hans Neuser; Klaus Kurzidim; Alexander Berkowitsch; Marcus Koller; Johannes Heintze; Ursula Scholz; Ulrike Wetzel; Michael A E Schneider; Dieter Horstkotte; Christian W Hamm; Heinz-Friedrich Pitschner Journal: J Am Coll Cardiol Date: 2008-07-22 Impact factor: 24.094
Authors: Erik Wissner; Andreas Metzner; Petr Neuzil; Jan Petru; Jan Skoda; Lucia Sediva; Dietmar Kivelitz; Peter Wohlmuth; Jiri Weichet; Bas Schoonderwoerd; Peter Rausch; Aleksander Bardyszewski; Roland R Tilz; Feifan Ouyang; Vivek Y Reddy; Karl-Heinz Kuck Journal: Europace Date: 2013-08-09 Impact factor: 5.214